IP Library Granted Patent US 8,951,730
Granted Patent B2
US 8,951,730 · App. 13/789,409 · Granted Feb 10, 2015

Compositions for detecting small RNAs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,951,730
App. No.
13/789,409
Granted
Feb 10, 2015
Kind
B2
Abstract

Compositions and reaction mixtures are provided for the detection of small RNA target nucleic acids, preferably miRNA target nucleic acids, wherein the compositions and reaction mixtures provide for sensitive and specific detection of the target nucleic acids. The compositions and reaction mixtures include one or more of a first amplification oligomer that is preferably an extender primer, a target capture oligomer that is preferably at least partially double stranded, a promoter primer/provider, a reverse primer that is preferably a universal primer and a detection probe. The compositions and reaction mixtures are useful for diagnostics, prognostics, monitoring the effectiveness of treatment and/or determining a treatment.

Claims (22)

1. An amplification reaction mixture comprising:

(a) a miR-221 target capture probe that forms under hybridizing conditions at least a partially double-stranded structure that is a hairpin structure made up of a contiguous linear sequence that includes an internal target hybridizing sequence that is substantially complementary to all or a portion of SEQ ID NO:44 and that forms a single-stranded loop portion of the hairpin structure, wherein the internal target hybridizing sequence is flanked by a capture region and by a terminal region that binds to the capture region to form a double-stranded stem portion of the hairpin structure, wherein the capture region further comprises a substantially homopolymeric nucleic acid sequence and the terminal region further comprises a substantially homopolymeric nucleic acid sequence that is complementary to the capture region sequence, and wherein the miR-221 target capture probe is at least 95% identical to SEQ ID NO:24; and

(b) a first amplification oligomer configured to hybridize to a miR-221 target nucleic acid that is an extender primer comprising a 3′ target hybridizing sequence and a 5′ extension nucleic acid sequence, wherein the 3′ target hybridizing sequence is substantially identical to about 9 or more contiguous nucleic acids at the 5′ end of the target hybridizing sequence of the miR-221 target capture probe.

2. The amplification reaction mixture of claim 1 , further comprising a miR-182 target capture probe that forms under hybridizing conditions at least a partially double-stranded structure that is a hairpin structure made up of a contiguous linear sequence that includes an internal target hybridizing sequence that is substantially complementary to all or a portion of SEQ ID NO:41 and that forms a single-stranded loop portion of the hairpin structure, wherein the internal target hybridizing sequence is flanked by a capture region and by a terminal region that binds to the capture region to form a double-stranded stem portion of the hairpin structure and wherein the capture region further comprises a substantially homopolymeric nucleic acid sequence and the terminal region further comprises a substantially homopolymeric nucleic acid sequence that is complementary to the capture region sequence.

3. The amplification reaction mixture of claim 1 , further comprising a first amplification oligomer configured to hybridize to a miR-182 target nucleic acid that is an extender primer comprising a 3′ target hybridizing sequence and a 5′ extension nucleic acid sequence, wherein the 3′ target hybridizing sequence is substantially identical to about 9 or more contiguous nucleic acids at the 5′ end of the target hybridizing sequence of the miR-182 target capture probe.

4. The amplification reaction mixture of claim 1 , further comprising a promoter based oligomer configured to specifically hybridize to a miR-221 target nucleic acid, that comprises a target hybridizing sequence that is substantially complementary to 12 or more contiguous nucleic acids on 3′ end of the miR-221 target capture probe.

5. The amplification reaction mixture of claim 4 , wherein the miR-221 promoter based oligomer is at least 95% identical to SEQ ID NO:11.

6. The amplification reaction mixture of claim 4 , wherein the miR-221 promoter based oligomer is SEQ ID NO:11.

7. The amplification reaction mixture of claim 1 , wherein the miR-221 target capture probe is SEQ ID NO:24.

8. The amplification reaction mixture of claim 1 , wherein the miR-221 extender primer is at least 95% identical to SEQ ID NO:17.

9. The amplification reaction mixture of claim 1 , wherein the miR-221 extender primer is SEQ ID NO:17.

10. The amplification reaction mixture of claim 2 , further comprising a promoter based oligomer configured to specifically hybridize to a miR-182 target nucleic acid, that comprises a target hybridizing sequence that is substantially complementary to 12 or more contiguous nucleic acids on 3′ end of the miR-182 target capture probe.

11. The amplification reaction mixture of claim 10 , wherein the promoter based oligomer is at least 95% identical to SEQ ID NO:10.

12. The amplification reaction mixture of claim 10 , wherein the promoter based oligomer is SEQ ID NO:10.

13. The amplification reaction mixture of claim 2 , wherein the miR-182 target capture probe is at least 95% identical to SEQ ID NO:23.

14. The amplification reaction mixture of claim 2 , wherein the miR-182 target capture probe is SEQ ID NO:23.

15. The amplification reaction mixture of claim 3 , wherein the miR-182 extender primer is at least 95% identical to SEQ ID NO:16.

16. The amplification reaction mixture of claim 15 , wherein the miR-182 extender primer is SEQ ID NO:16.

17. The amplification reaction mixture of claim 1 , further comprising a reverse primer.

18. The amplification reaction mixture of claim 2 , further comprising a universal reverse primer.

19. The amplification reaction mixture of claim 1 , wherein the target capture probe comprises at least one 2′-OMe residue in the target hybridizing sequence.

20. The amplification reaction mixture of claim 2 , wherein the target capture probe comprises at least one 2′-OMe residue in the target hybridizing sequence.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2013
From: SIVA, AMARA; REYNOLDS, MARK ALAN
To: GEN-PROBE INCORPORATED
Reel/Frame 029946/0982 →